Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis

ClinicalTrials.gov ID: NCT03478787

Public ClinicalTrials.gov record NCT03478787. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 3:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Open Label, Efficacy Assessor-Blinded Study of Risankizumab Compared to Secukinumab for the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy

Study identification

NCT ID
NCT03478787
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
327 participants

Conditions and interventions

Conditions

Interventions

  • risankizumab Drug
  • secukinumab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Not listed
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 7, 2018
Primary completion
Jul 7, 2020
Completion
Jul 7, 2020
Last update posted
Jul 12, 2021

2018 – 2020

United States locations

U.S. sites
28
U.S. states
16
U.S. cities
27
Facility City State ZIP Site status
Advanced Research Associates - Glendale /ID# 204335 Glendale Arizona 85308
Alliance Dermatology and MOHs /ID# 204336 Phoenix Arizona 85032
Bakersfield Derma & Skin Cance /ID# 202115 Bakersfield California 93309
Center for Dermatology Clin Res /ID# 202116 Fremont California 94538
Dermatology Res. Assoc., CA /ID# 202170 Los Angeles California 90045
UC Davis Health /ID# 202263 Sacramento California 95816
Medderm Associates /ID# 202162 San Diego California 92103
UConn Health Main /ID# 201745 Farmington Connecticut 06032
Tory P Sullivan, MD PA /ID# 202177 North Miami Beach Florida 33162-4708
Renstar Medical Research /ID# 202113 Ocala Florida 34470
Progressive Medical Research /ID# 202183 Port Orange Florida 32127
Integrated Clinical Research LLC /ID# 202152 West Palm Beach Florida 33406-6063
Dermatology Specialists Resear /ID# 202145 Louisville Kentucky 40241
Dermatology and Skin Cancer Specialists, LLC /ID# 203938 Rockville Maryland 20850
ORA, Inc. /ID# 204342 Andover Massachusetts 01810
Beth Israel Deaconess Medical Center /ID# 204340 Boston Massachusetts 02215-5400
Minnesota Clinical Study Center /ID# 202369 New Brighton Minnesota 55112
Central Dermatology, PC /ID# 202156 St Louis Missouri 63117
Psoriasis Treatment Ctr of Central NJ /ID# 202107 East Windsor New Jersey 08520
Synexus Research Cincinnati /ID# 202161 Cincinnati Ohio 45236
Oregon Derm & Res. Ctr /ID# 201652 Portland Oregon 97210
Oregon Medical Res Center PC /ID# 201651 Portland Oregon 97223
Clinical Partners, LLC /ID# 201736 Johnston Rhode Island 02919
Center for Clinical Studies - Houston (Binz) /ID# 202178 Houston Texas 77004-8097
Progressive Clinical Research /ID# 202155 San Antonio Texas 78229
Center for Clinical Studies - Webster TX /ID# 202154 Webster Texas 77598
University of Utah /ID# 204035 Salt Lake City Utah 84112-5500
Froedtert Mem Lutheran Hosp /ID# 204896 Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03478787, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 12, 2021 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03478787 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →